𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Cost-effectiveness of adding bevacizumab to first line therapy for patients with advanced ovarian cancer

✍ Scribed by Mehta, Darshan A.; Hay, Joel W.

Book ID
121502818
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
300 KB
Volume
132
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Centralization of care for patients with
Centralization of care for patients with advanced-stage ovarian cancer : A cost-effectiveness analysis
✍ Robert E. Bristow; Antonio Santillan; Teresa P. Diaz-Montes; Ginger J. Gardner; πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 363 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The objective of this study was to evaluate the cost‐effectiveness of centralized referral of patients with advanced‐stage epithelial ovarian cancer who underwent primary cytoreductive surgery and adjuvant chemotherapy. ## METHODS. A decision‐analysis model was used to